Breast Biopsy Market Growth & Key Business Strategies by Leading Industry Players Hologic Inc., Leica Biosystems Nussloch GmbH , C. R. Bard, Inc., Becton and Dickinson Company, Argon Medical Devices, Cook Medical Incorporated

Global Breast Biopsy Market was valued at $976.7 million in 2016, and is projected to reach at $1,420 million by 2023, growing at a CAGR of 5.3% from 2017 to 2023. Breast biopsy is a test performed to remove tissue or fluid from the suspicious area of the patient’s body, while the removed sample is further examined to check the presence of breast cancer. There are different types of biopsy procedures depending on the product, such as vacuum assisted biopsy (VAB), core needle biopsy (CNB), and fine needle aspiration biopsy (FNAB), recommended by the doctor based on the location, size, and other characteristics of the breast abnormality.

Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-sample/1067

A breast biopsy is the procedure of locating a diseased tissue in the breast and collecting the specimen sample of the area for further examination and diagnosis. Breast biopsies are performed by using minimally invasive biopsy systems, owing to minimal disfigurement and pain. Non-invasive biopsy techniques provide preventive measures that assist physicians in diagnosing and treating high-risk breast cancer. This information prevents the application of chemotherapy in breast cancer, reducing the complexities of chemo-radiations. Vacuum assisted breast biopsy devices (VAB), core needle biopsies and fine needle aspiration biopsy are commonly used to perform biopsy procedures.

The major factors that boost the market growth include rise in incidence of breast cancer, growth in awareness toward cancer screening programs, and increase in demand for minimal invasive breast biopsies. Moreover, the ongoing technological advancements of diagnostic and treatment technology for breast cancer have undergone a gradual transition from open surgery to minimal invasive biopsy procedures. Breast cancer is the most common type of cancer in women, especially in the U.S., where it is the second leading cause of death propels the demand for breast biopsy procedures. Furthermore, requirement of robust measures for disease control, the thrust for newer technologies has led to the development of minimal invasive surgeries. This has made breast biopsy as preferred modality to diagnose breast cancer and identify complex tumors and make accurate diagnosis. However, lack of awareness toward the availability of novel breast biopsy techniques and risk of infection involved in the procedures are projected to hamper the market growth.

The core needle biopsy (CNB) segment dominated the global market in 2016, and is expected to maintain this trend throughout the analysis period, owing to the less invasive procedure compared to others and it provides more definitive diagnosis. Moreover, use of CNB and ultrasonographic and mammographic guidance is highly accurate for diagnosing breast cancer that supplements the market growth.

Get More Information @ https://www.alliedmarketresearch.com/purchase-enquiry/1067

The ultrasound guided biopsy is poised to grow at the highest rate during the forecast period, owing to the sound waves used instead ionizing radiation to locate abnormality or lump and is less invasive in nature with reduced scars. Ultrasound guided biopsy segment is expected to grow at a high CAGR of 6.1% from 2017 to 2023.

Key players operating in the market include Hologic Inc., Leica Biosystems Nussloch GmbH (Devicor Medical Products, Inc.), C. R. Bard, Inc., Becton and Dickinson Company, Argon Medical Devices, Cook Medical Incorporated, Encapsule medical Devices LLC., Ethicon Endo Surgery (Johnson & Johnson), Intact Medical Corporation, and Galini SRL.

LIST OF TABLES

TABLE 1. GLOBAL BREAST BIOPSY MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 2. GLOBAL VACUUM ASSISTED BIOPSY (VAB) MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 3. GLOBAL CORE NEEDLE BIOPSY (CNB) MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 4. GLOBAL FINE NEEDLE ASPIRATION BIOPSY (FNAB) MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 5. GLOBAL BREAST BIOPSY MARKET, BY IMAGE GUIDED TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 6. GLOBAL MRI-GUIDED BREAST BIOPSY MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 7. GLOBAL ULTRASOUND GUIDED BREAST BIOPSY MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 8. GLOBAL MAMMOGRAPHY GUIDED STEREOTACTIC BIOPSY MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 9. GLOBAL CT-GUIDED BREAST BIOPSY MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 10. GLOBAL OTHER IMAGE GUIDED BREAST BIOPSY MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 11. GLOBAL BREAST BIOPSY MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 12. GLOBAL BREAST BIOPSY MARKET FOR DIAGNOSTIC CENTER, BY REGION, 2016-2023 ($MILLION)
TABLE 13. GLOBAL BREAST BIOPSY MARKET FOR HOSPITAL, BY REGION, 2016-2023 ($MILLION)
TABLE 14. GLOBAL BREAST BIOPSY MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 15. NORTH AMERICA BREAST BIOPSY MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 16. NORTH AMERICA BREAST BIOPSY MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 17. NORTH AMERICA BREAST BIOPSY MARKET, BY IMAGE GUIDED TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 18. NORTH AMERICA BREAST BIOPSY MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 19. EUROPE BREAST BIOPSY MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 20. EUROPE BREAST BIOPSY MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 21. EUROPE BREAST BIOPSY MARKET, BY IMAGE GUIDED TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 22. EUROPE BREAST BIOPSY MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 23. ASIA-PACIFIC BREAST BIOPSY MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 24. ASIA-PACIFIC BREAST BIOPSY MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 25. ASIA-PACIFIC BREAST BIOPSY MARKET, BY IMAGE GUIDED TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 26. ASIA-PACIFIC BREAST BIOPSY MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 27. LAMEA BREAST BIOPSY MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 28. LAMEA BREAST BIOPSY MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 29. LAMEA BREAST BIOPSY MARKET, BY IMAGE GUIDED TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 30. LAMEA BREAST BIOPSY MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 31. HOLOGIC: COMPANY SNAPSHOT
TABLE 32. HOLOGIC: OPERATING SEGMENTS
TABLE 33. LEICA BIOSYSTEMS: COMPANY SNAPSHOT
TABLE 34. LEICA BIOSYSTEMS: OPERATING SEGMENTS
TABLE 35. C. R. BARD: COMPANY SNAPSHOT
TABLE 36. C. R. BARD: OPERATING SEGMENTS
TABLE 37. BECTON DICKINSON: COMPANY SNAPSHOT
TABLE 38. BECTON DICKINSON: OPERATING SEGMENTS
TABLE 39. ARGON: COMPANY SNAPSHOT
TABLE 40. ARGON: OPERATING SEGMENTS
TABLE 41. COOK MEDICAL: COMPANY SNAPSHOT
TABLE 42. COOK MEDICAL: OPERATING SEGMENTS
TABLE 43. ENCAPSULE MEDICAL: COMPANY SNAPSHOT
TABLE 44. ENCAPSULE MEDICAL: OPERATING SEGMENTS
TABLE 45. ETHICON: COMPANY SNAPSHOT
TABLE 46. ETHICON: OPERATING SEGMENTS
TABLE 47. INTACT MEDICAL: COMPANY SNAPSHOT
TABLE 48. INTACT MEDICAL: OPERATING SEGMENTS
TABLE 49. GALINI: COMPANY SNAPSHOT
TABLE 50. GALINI: OPERATING SEGMENTS

Access Full Summery @ https://www.alliedmarketresearch.com/press-release/breast-biopsy-market.html

About Us

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com

This release was published on openPR.